[Vertigo in adolescents with hemicrania].
Lombardi
D
D
UOC Pediatria, ASL. n. 12, Versilia, Italy.
Merusi
I
I
Bottone
U
U
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000627:therapeutic use; D000293:Adolescent; D000367:Age Factors; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005444:Flunarizine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000150:complications* / Q000175:diagnosis / Q000517:prevention & control; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014717:Vertigo / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control
D000928:Antidepressive Agents; D014665:Vasodilator Agents; D006916:5-Hydroxytryptophan; D005444:Flunarizine